您現在的位置 :

醫療團隊

專業的醫護人員，提供最佳的醫療服務

醫師介紹

  •

葉光揚醫師

癌症治療、細胞治療、基礎研究、臨床試驗
  • 國語,英語,閩南語
  • 教授
醫師網路掛號
直接點選進入醫師網路掛號畫面
醫師資歷
  • 現職
    • 基隆長庚血液腫瘤科主任
    • 長庚醫院教授
    • 基隆長庚血液腫瘤科主治醫師
  • 學歷
    • 中山醫學院 醫學系
    • 美國University of Rochester, Ph.D. Immunology
  • 經歷
    • 基隆長庚癌症中心主任
    • 基隆長庚內科部部長
    • 林口長庚腫瘤科主治醫師
    • 林口長庚內科部住院醫師
    • 林口長庚腫瘤科研究員
    • 羅東博愛醫院血液腫瘤科主任
  • 學會與認證
    • 台灣內科醫學會
    • 中華民國癌症醫學會
    • 台灣癌症安寧緩和醫學會
    • 台灣靜脈暨腸道營養醫會
    • 台灣乳房醫學會
  • 論文及期刊發表
    • Low-dose zoledronic acid reduces spinal cord metastasis in pulmonary adenocarcinoma with neuroendocrine differentiation.
      Anti-Cancer Drug. 2012, 23:970-8
      Ying-Ying Li, John, W-C Chang, Ling-Ling Hsieh , Shu-Mei Chen, Kun-Yun Yeh*
    • Low body mass index at 3 months following adjuvant chemoradiation affects survival of postoperative locally advanced oral cavity cancer patients in an area endemic for betel quid chewing.
      Laryngoscope 2012, 122:2193-8
      Pei-Hung Chang, Cheng-Hsu Wang., Jen-Seng Huang, Chien-Hong Lai, Tsung-Han Wu, Yii-Jeng Lan, Chien-Sheng Tsai, Eric Yen-Chao Chen, Shih-Wei Yang, and Kun-Yun Yeh*
    • Early Nutrition Support in Non-metastatic Stage IV Oral Cavity Cancer Patients Undergoing Adjuvant Concurrent Chemoradiotherapy: Analysis of Treatment Tolerance and Outcome in an Area Endemic for Betel-Quid Chewing.
      Supportive Care in Cancer. 2012, 20:1169-1174
      Wang, C-H, Wang, H-M, Pang, Y-P, Yeh, K-Y*.
    • Unusual Hematogenous Brain Metastasis in Malignant Fibrous Histiocytoma of the Maxillary Sinus.
      Internal Journal of Clinical Oncology. 2012 17 (1): 69-74
      Wu, T-H., Shih, C-W., Huang, J-S., Wang, C-H., Yeh, K-Y*.
    • A multiple-centre phase II study of weekly docetaxel and oxaliplatin as first-line treatment in patients with advanced gastric cancer.
      Gastric Cancer. 2012 15:49-55.
      Chen, J-S., Chen, Y-Y., Huang, J-S., Yeh, K-Y., Chen,P-T., Shen, W-C., Hsu, H-C., Lin, Y-C., Wang, H-M.
    • Chromogranin A Is a Reliable Biomarker for Gastroenteropancreatic Neuroendocrine Tumors in an Asian Population of Patients.
      Neuroendocrinology 2012. 95:344-350.
      Wen-Chi Chou, Yu-Shin Hung, Jun-Te Hsu, Jen-Shi Chen, Chang-Hsien Lu, Tsann-Long Hwang, Kun-Ming Rau Kun-Yun Yeh, Tse-Ching Chen, Chien-Feng Sun.
    • Dual-colour chromogenic in-situ hybridization is a potential alternative to fluorescence in-situ hybridization in HER2 testing.
      Histopathology. 2011, 59, 9840
      Hwang, CC., Pintye, M., Chang, LC., Chen, HY., Yeh, KY., Chein, H., Lee, N., Chen, J.
    • Biochemotherapy with Carmustine, Cisplatin, Dacarbazine, Tamoxifen and Low-dose Interleukin-2 for Patients with Metastatic Malignant Melanoma 2011.
      Chang Gung Medical Journal. 2011, 34:478-86
      Po-Jung Su, Jen-Shi Chen, Chuang-Chi Liaw, Hsien-Kun Chang., Hung-Ming Wang, Tsia-Sheng Yang, Yung-Chang Lin, Chi-Ting Liau, Hsin-Yi Yang, Kun-Yun Yeh, Ming-Mo Ho, Nai-Jun Chang, Cheng-Hsu Wang, John Wen-Chen Chang.
    • Oxaliplatin induced coronary vasospasm manifesting as Kounis syndrome
      Journal of Clinical Oncology, 2011 29(31): e776-e778
      Chang, P-H., Hung, M-J., Yeh, K-Y., Yang, S-Y., Wang, C-H.
    • Tumor Growth Inhibition of Metatstatic Nasopharyngeal Carcinoma Cell Lines by Low Dose of Arsenic Trioxide via Alteration of Cell-cycle Progression and Induction of Apoptosis
      Head and Neck 2011, 33:734-742
      Yeh, K-Y., Chang, J W-C., Li, Y-Y., Wang, C-H., Wang, H-M.
    • Zoledronic acid induces cell-cycle prolongation in murine lung cancer cells by perturbing cyclin and Ras expression
      Anti-Cancer Drug 2011. 22:89-98
      Li, Y-Y., Chang, J W-C., Liu, Y-C., Wang, C-H, Chang, H-J, Tsai, M-C, Su, S. P., Yeh, K-Y*.